Active, Not Recruiting
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
NCT06317311
- Conditions
- Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Chiba, Japan
- GSK Investigational Site Ehime, Japan
- GSK Investigational Site Fukuoka, Japan